EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.3.1.39 | Adenocarcinoma |
16084671 |
Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 2.3.1.39 | Adenocarcinoma |
16564913 |
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.3.1.39 | Adenocarcinoma |
16809439 |
Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators? |
causal interaction
ongoing research
therapeutic application
unassigned |
2
3
3
0 |
| 2.3.1.39 | Adenocarcinoma |
18802406 |
Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
1
3
0 |
| 2.3.1.39 | Adenocarcinoma |
19471962 |
Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinoma. |
diagnostic usage
ongoing research
unassigned |
3
1
0 |
| 2.3.1.39 | Adenocarcinoma |
21757596 |
Is there a role for fatty acid synthase in the diagnosis of prostatic adenocarcinoma?: A comparison with AMACR. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 2.3.1.39 | Adenocarcinoma |
21801966 |
Angiotensin II type 2 receptor blockade inhibits fatty acid synthase production through activation of AMP-activated protein kinase in pancreatic cancer cells. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
2
0 |
| 2.3.1.39 | Adenocarcinoma |
22585994 |
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
3
0 |
| 2.3.1.39 | Adenocarcinoma |
26622804 |
A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients. |
causal interaction
diagnostic usage
unassigned |
3
2
0 |
| 2.3.1.39 | Adenocarcinoma of Lung |
28400509 |
Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
